Skip to content

Application of esketamine as a local anesthetic adjuvant for ultrasound-guided paravertebral nerve block in thoracoscopic surgery

Application of esketamine as a local anesthetic adjuvant for ultrasound-guided paravertebral nerve block in thoracoscopic surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042597
Enrollment
Unknown
Registered
2021-01-24
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative analgesia

Interventions

Control group:0.5% ropivacaine 0.3ml/kg paravertebral block was given
esketamine group:0.5% ropivacaine 0.3ml/kg with esketamine 0.5mg/kg

Sponsors

The Second Affiliated Hospital of Nantong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65; 2, ASA I ~ III level; 3. Pulmonary tumor surgery under general anesthesia, including wedge resection of lung and lung segment Resection, partial pulmonary resection, lobectomy and radical resection of unilateral lung cancer; 4. Plan to stay in hospital >= 48 hours after surgery.

Exclusion criteria

Exclusion criteria: 1.Have a history of allergy or contraindication to ropidocaine, ketamine, or nonsteroidal anti-inflammatory drugs (NSAIDs) (severe risk of elevated blood pressure and intracranial pressure, poorly controlled or untreated hypertension, untreated or undertreated hyperthyroidism, or gastrointestinal bleeding); 2.Have mental illness and other chronic pain; 3.Unable to read and write Chinese, communication barriers; 4.Emergency surgery or trauma patients; 5.Previous history of thoracotomy or intraoperative knowledge;Additional intercostal incisions were needed during the operation. 6.Admitted to ICU after surgery; 7.Unwillingness to use intravenous analgesia pumps and refusal to participate.

Design outcomes

Primary

MeasureTime frame
Morphine consumption 24h after surgery;

Secondary

MeasureTime frame
NRS scores;the time of first remedial analgesia;Recovery quality score;

Countries

China

Contacts

Public ContactBoxiang Du

The Second Affiliated Hospital of Nantong University

boxiang_du@163.com+86 15262839991

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026